Fullerton Management Pte Ltd - Net Worth and Insider Trading

Fullerton Management Pte Ltd Net Worth

The estimated net worth of Fullerton Management Pte Ltd is at least $119 Million dollars as of 2024-11-13. Fullerton Management Pte Ltd is the 10% Owner of Portola Pharmaceuticals Inc and owns about 6,583,568 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $119 Million. Details can be seen in Fullerton Management Pte Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fullerton Management Pte Ltd has not made any transactions after 2015-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Fullerton Management Pte Ltd

To

Fullerton Management Pte Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fullerton Management Pte Ltd owns 12 companies in total, including Coherus BioSciences Inc (CHRS) , Vir Biotechnology Inc (VIR) , and Guardant Health Inc (GH) among others .

Click here to see the complete history of Fullerton Management Pte Ltd’s form 4 insider trades.

Insider Ownership Summary of Fullerton Management Pte Ltd

Ticker Comapny Transaction Date Type of Owner
CHRS Coherus BioSciences Inc 2017-08-24 10 percent owner
VIR Vir Biotechnology Inc 2019-10-10 10 percent owner
GH Guardant Health Inc 2018-10-03 10 percent owner
LIMIT LIMIT 2015-07-29 10 percent owner
LIMIT LIMIT 2018-03-28 10 percent owner
LIMIT LIMIT 2017-06-01 10 percent owner
LIMIT LIMIT 2016-05-05 10 percent owner
LIMIT LIMIT 2006-10-19 10 percent owner
LIMIT LIMIT 2021-05-25 10 percent owner
LIMIT LIMIT 2021-12-03 10 percent owner
LIMIT LIMIT 2021-07-15 10 percent owner
LIMIT LIMIT 2022-08-19 10 percent owner

Fullerton Management Pte Ltd Latest Holdings Summary

Fullerton Management Pte Ltd currently owns a total of 1 stock. Fullerton Management Pte Ltd owns 6,583,568 shares of Portola Pharmaceuticals Inc (PTLA) as of December 9, 2015, with a value of $119 Million.

Latest Holdings of Fullerton Management Pte Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PTLA Portola Pharmaceuticals Inc 2015-12-09 6,583,568 18.03 118,701,731

Holding Weightings of Fullerton Management Pte Ltd


Fullerton Management Pte Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Fullerton Management Pte Ltd has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the acquisition of 750,000 shares on December 9, 2015, which cost Fullerton Management Pte Ltd around $36 Million.

Insider Trading History of Fullerton Management Pte Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fullerton Management Pte Ltd Trading Performance

GuruFocus tracks the stock performance after each of Fullerton Management Pte Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fullerton Management Pte Ltd is -40.34%. GuruFocus also compares Fullerton Management Pte Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fullerton Management Pte Ltd within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fullerton Management Pte Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fullerton Management Pte Ltd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.7 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Fullerton Management Pte Ltd Ownership Network

Ownership Network List of Fullerton Management Pte Ltd

No Data

Ownership Network Relation of Fullerton Management Pte Ltd

Insider Network Chart

Fullerton Management Pte Ltd Owned Company Details

What does Coherus BioSciences Inc do?

Who are the key executives at Coherus BioSciences Inc?

Fullerton Management Pte Ltd is the 10 percent owner of Coherus BioSciences Inc. Other key executives at Coherus BioSciences Inc include director & President and CEO Dennis M Lanfear , Chief Financial Officer Mcdavid Stilwell , and See Remarks Bryan J Mcmichael .

Coherus BioSciences Inc (CHRS) Insider Trades Summary

Over the past 18 months, Fullerton Management Pte Ltd made no insider transaction in Coherus BioSciences Inc (CHRS). Other recent insider transactions involving Coherus BioSciences Inc (CHRS) include a net sale of 223,100 shares made by Dennis M Lanfear ,

In summary, during the past 3 months, insiders sold 0 shares of Coherus BioSciences Inc (CHRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 223,100 shares of Coherus BioSciences Inc (CHRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 223,100 shares.

Coherus BioSciences Inc (CHRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Coherus BioSciences Inc Insider Transactions

No Available Data

Fullerton Management Pte Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Fullerton Management Pte Ltd. You might contact Fullerton Management Pte Ltd via mailing address: 60b Orchard Road #06-18 Tower 2, The Atrium@orchard, Singapore U0 238891.